Page last updated: 2024-10-24

cetyltrimethylammonium ion and Retinal Degeneration

cetyltrimethylammonium ion has been researched along with Retinal Degeneration in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STIDWORTHY, GH1
ELLIS, PJ1
GOTTSCHALK, RG1

Other Studies

1 other study available for cetyltrimethylammonium ion and Retinal Degeneration

ArticleYear
Separation of sulfated urinary acid mucopolysaccharides utilizing cetyltrimethylammonium bromide and ethyl alcohol.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1963, Volume: 112

    Topics: Ammonium Compounds; Anti-Infective Agents, Local; Cetrimonium; Cetrimonium Compounds; Ethanol; Glyco

1963